Home » Defactinib in Combination With Weekly Paclitaxel Achieves a Complete Response in Platinum-Resistant Ovarian Cancer
Defactinib in Combination With Weekly Paclitaxel Achieves a Complete Response in Platinum-Resistant Ovarian Cancer
Verastem has achieved positive results in a study of defactinib in platinum-resistant ovarian cancer patients.
Businesswire
Businesswire
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May